Scolaris Content Display Scolaris Content Display

Tratamiento de la invaginación intestinal en niños

Appendices

Appendix 1. CENTRAL search strategy

CENTRAL (2016, Issue 8)

#1 MeSH descriptor Intussusception explode all trees
#2 ((intestin* and invagination*) or intususcep* or intussuscep*):ti,ab,kw
#3 (#1 OR #2)
#4 MeSH descriptor Infant explode all trees
#5 MeSH descriptor Child explode all trees
#6 (infant* or child* or newborn*):ti,ab,kw
#7 (#4 OR #5 OR #6)
#8 (#3 AND #7)

Appendix 2. MEDLINE search strategy

MEDLINE (Ovid 1950 to September 2016)

1. exp Intussusception/
2. ((intestin* and invagination*) or intususcep* or intussuscep*).mp.

3. 1 or 2
4. exp Infant/
5. exp Child/
6. (infant* or child* or newborn*).mp.

7. 4 or 5 or 6
8. 3 and 7
9. randomized controlled trial.pt.
10. controlled clinical trial.pt.
11. randomized.ab.
12. placebo.ab.
13. drug therapy.fs.

14. Randomly.ab.
15. trial.ab.
16. groups.ab.
17. 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18. exp animals/ not humans.sh.
19. 17 not 18
20. 8 and 19

Appendix 3. Embase search strategy

Embase (Ovid, 1974 to September 2016)

1. exp intussusception/
2. ((intestin* and invagination*) or intususcep* or intussuscep*).mp.
3. 1 or 2
4. exp child/
5. (infant* or child* or newborn*).mp.
6. 4 or 5
7. 3 and 6
8. CROSSOVER PROCEDURE.sh.
9. DOUBLE‐BLIND PROCEDURE.sh.
10. SINGLE‐BLIND PROCEDURE.sh.
11. (crossover* or cross over*).ti,ab.
12. placebo*.ti,ab.
13. (doubl* adj blind*).ti,ab.
14. allocat*.ti,ab.
15. trial.ti.
16. RANDOMIZED CONTROLLED TRIAL.sh.
17. random*.ti,ab.
18. 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17
19. (exp animal/ or exp invertebrate/ or animal.hw. or nonhuman/) not (exp human/ or human cell/ or (human or humans or man or men or wom?n).ti.)
20. 18 not 19
21. 7 and 20

Appendix 4. Science Citation Index search strategy

Science Citation Index Expanded (via Web of Science) (1900 to September 2016)

#1 Topic=(((intestin* and invagination*) or intususcep* or intussuscep*))
#2 Topic=((infant* or child* or newborn*))
#3 Topic=((controlled trial or controlled clinical trial or placebo or clinical trial or random* or trial or cct or rct))
#4 (#3 AND #2 AND #1)

Appendix 5. Biosis Previews search strategy

Biosis Previews (via Web of Science) (1969 to September 2016)

#1 Topic=(((intestin* and invagination*) or intususcep* or intussuscep*))
#2 Topic=((infant* or child* or newborn*))
#3 Topic=((controlled trial or controlled clinical trial or placebo or clinical trial or random* or trial or cct or rct))
#4 (#3 AND #2 AND #1)

Appendix 6. Criteria for judging risk of bias in the 'Risk of bias' assessment tool

RANDOM SEQUENCE GENERATION

Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence

Criteria for a judgement of ‘Low risk’ of bias

The investigators describe a random component in the sequence generation process such as:

  • Referring to a random number table;

  • Using a computer random number generator;

  • Coin tossing;

  • Shuffling cards or envelopes;

  • Throwing dice;

  • Drawing of lots;

  • Minimization*.

*Minimization may be implemented without a random element, and this is considered to be equivalent to being random.

Criteria for the judgement of ‘High risk’ of bias.

The investigators describe a non‐random component in the sequence generation process. Usually, the description would involve some systematic, non‐random approach, for example:

  • Sequence generated by odd or even date of birth;

  • Sequence generated by some rule based on date (or day) of admission;

  • Sequence generated by some rule based on hospital or clinic record number.

Other non‐random approaches happen much less frequently than the systematic approaches mentioned above and tend to be obvious. They usually involve judgement or some method of non‐random categorization of participants, for example:

  • Allocation by judgement of the clinician;

  • Allocation by preference of the participant;

  • Allocation based on the results of a laboratory test or a series of tests;

  • Allocation by availability of the intervention.

Criteria for the judgement of ‘Unclear risk’ of bias.

Insufficient information about the sequence generation process to permit judgement of ‘Low risk’ or ‘High risk’.

ALLOCATION CONCEALMENT

Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment.

Criteria for a judgement of ‘Low risk’ of bias.

Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent method, was used to conceal allocation:

  • Central allocation (including telephone, web‐based and pharmacy‐controlled randomization);

  • Sequentially numbered drug containers of identical appearance;

  • Sequentially numbered, opaque, sealed envelopes.

Criteria for the judgement of ‘High risk’ of bias.

Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation based on:

  • Using an open random allocation schedule (e.g. a list of random numbers);

  • Assignment envelopes were used without appropriate safeguards (e.g. if envelopes were unsealed or non­opaque or not sequentially numbered);

  • Alternation or rotation;

  • Date of birth;

  • Case record number;

  • Any other explicitly unconcealed procedure.

Criteria for the judgement of ‘Unclear risk’ of bias.

Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’. This is usually the case if the method of concealment is not described or not described in sufficient detail to allow a definite judgement – for example if the use of assignment envelopes is described, but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.

BLINDING OF PARTICIPANTS AND PERSONNEL

Performance bias due to knowledge of the allocated interventions by participants and personnel during the study.

Criteria for a judgement of ‘Low risk’ of bias.

Any one of the following:

  • No blinding or incomplete blinding, but the review authors judge that the outcome not likely to be influenced by lack of blinding;

  • Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.

Criteria for the judgement of ‘High risk’ of bias.

Any one of the following:

  • No blinding or incomplete blinding, and the outcome is likely to be influenced by lack of blinding;

  • Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken, and the outcome is likely to be influenced by lack of blinding.

Criteria for the judgement of ‘Unclear risk’ of bias.

Any one of the following:

  • Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’;

  • The study did not address this outcome.

BLINDING OF OUTCOME ASSESSMENT

Detection bias due to knowledge of the allocated interventions by outcome assessors.

Criteria for a judgement of ‘Low risk’ of bias.

Any one of the following:

· No blinding of outcome assessment, but the review authors judge that the outcome measurement is not likely to be influenced by lack of blinding;

· Blinding of outcome assessment ensured, and unlikely that the blinding could have been broken.

Criteria for the judgement of ‘High risk’ of bias.

Any one of the following:

  • No blinding of outcome assessment, and the outcome measurement is likely to be influenced by lack of blinding;

  • Blinding of outcome assessment, but likely that the blinding could have been broken, and the outcome measurement is likely to be influenced by lack of blinding.

Criteria for the judgement of ‘Unclear risk’ of bias.

Any one of the following:

  • Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’;

  • The study did not address this outcome.

INCOMPLETE OUTCOME DATA

Attrition bias due to amount, nature or handling of incomplete outcome data.

Criteria for a judgement of ‘Low risk’ of bias.

Any one of the following:

  • No missing outcome data;

  • Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing bias);

  • Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups;

  • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a clinically relevant impact on the intervention effect estimate;

  • For continuous outcome data, plausible effect size (difference in means or standardized difference in means) among missing outcomes not enough to have a clinically relevant impact on observed effect size;

  • Missing data have been imputed using appropriate methods.

Criteria for the judgement of ‘High risk’ of bias.

Any one of the following:

  • Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing data across intervention groups;

  • For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce clinically relevant bias in intervention effect estimate;

  • For continuous outcome data, plausible effect size (difference in means or standardized difference in means) among missing outcomes enough to induce clinically relevant bias in observed effect size;

  • ‘As‐treated’ analysis done with substantial departure of the intervention received from that assigned at randomization;

  • Potentially inappropriate application of simple imputation.

Criteria for the judgement of ‘Unclear risk’ of bias.

Any one of the following:

  • Insufficient reporting of attrition/exclusions to permit judgement of ‘Low risk’ or ‘High risk’ (e.g. number randomized not stated, no reasons for missing data provided);

  • The study did not address this outcome.

SELECTIVE REPORTING

Reporting bias due to selective outcome reporting.

Criteria for a judgement of ‘Low risk’ of bias.

Any of the following:

  • The study protocol is available and all of the study’s pre‐specified (primary and secondary) outcomes that are of interest in the review have been reported in the pre‐specified way;

  • The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that were pre‐specified (convincing text of this nature may be uncommon).

Criteria for the judgement of ‘High risk’ of bias.

Any one of the following:

  • Not all of the study’s pre‐specified primary outcomes have been reported;

  • One or more primary outcomes is reported using measurements, analysis methods or subsets of the data (e.g. subscales) that were not pre‐specified;

  • One or more reported primary outcomes were not pre‐specified (unless clear justification for their reporting is provided, such as an unexpected adverse effect);

  • One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta‐analysis;

  • The study report fails to include results for a key outcome that would be expected to have been reported for such a study.

Criteria for the judgement of ‘Unclear risk’ of bias.

Insufficient information to permit judgement of ‘Low risk’ or ‘High risk’. It is likely that the majority of studies will fall into this category.

OTHER BIAS

Bias due to problems not covered elsewhere in the table.

Criteria for a judgement of ‘Low risk’ of bias.

The study appears to be free of other sources of bias.

Criteria for the judgement of ‘High risk’ of bias.

There is at least one important risk of bias. For example, the study:

  • Had a potential source of bias related to the specific study design used; or

  • Has been claimed to have been fraudulent; or

  • Had some other problem.

Criteria for the judgement of ‘Unclear risk’ of bias.

There may be a risk of bias, but there is either:

  • Insufficient information to assess whether an important risk of bias exists; or

  • Insufficient rationale or evidence that an identified problem will introduce bias.

Study flow diagram for identification of randomised trials exploring management of intussusception in children.
Figuras y tablas -
Figure 1

Study flow diagram for identification of randomised trials exploring management of intussusception in children.

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
Figuras y tablas -
Figure 2

Risk of bias summary: review authors' judgements about each risk of bias item for each included study.

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
Figuras y tablas -
Figure 3

Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.

Comparison 1 Enema plus glucagon versus enema alone, Outcome 1 Successfully reduced intussusception.
Figuras y tablas -
Analysis 1.1

Comparison 1 Enema plus glucagon versus enema alone, Outcome 1 Successfully reduced intussusception.

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 1 Successfully reduced intussusception.
Figuras y tablas -
Analysis 2.1

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 1 Successfully reduced intussusception.

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 2 Bowel perforation(s).
Figuras y tablas -
Analysis 2.2

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 2 Bowel perforation(s).

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 3 Recurrent intussusception.
Figuras y tablas -
Analysis 2.3

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 3 Recurrent intussusception.

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 4 Bowel resection.
Figuras y tablas -
Analysis 2.4

Comparison 2 Enema plus dexamethasone versus enema alone, Outcome 4 Bowel resection.

Comparison 3 Air enema versus liquid enema, Outcome 1 Successfully reduced intussusception.
Figuras y tablas -
Analysis 3.1

Comparison 3 Air enema versus liquid enema, Outcome 1 Successfully reduced intussusception.

Summary of findings for the main comparison. Enema plus glucagon versus enema alone

Enema plus glucagon versus enema alone summary of findings table

Patient or population: children with intussusception
Setting: single centre, in‐patient setting
Intervention: liquid enema plus glucagon
Comparison: liquid enema alone

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

Number of participants
(studies)

Quality of the evidence
(GRADE)

Risk with liquid enema alone

Risk with liquid enema plus glucagon

Successfully reduced intussusception

Study population

RR 1.09
(0.94 to 1.26)

218
(2 studies)

Lowa

739 per 1000

805 per 1000
(694 to 931)

Moderate

649 per 1000

707 per 1000
(610 to 818)

Bowel perforation(s)

Outcome not reported in any studies

Recurrent intussusception

(follow‐up: 6 months)

Outcome not reported in any studies

Bowel resection

Outcome not reported in any studies

Postoperative complication(s)

Outcome not reported in any studies

*The risk in the intervention group (and its 95% confidence interval) is based on assumed risk in the comparison group and relative effect of the intervention (and its 95% CI)
CI: confidence interval; RR: risk ratio

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to the estimate of effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aDowngraded two levels for serious concerns for high risk of selection, attrition, and performance bias

Figuras y tablas -
Summary of findings for the main comparison. Enema plus glucagon versus enema alone
Summary of findings 2. Enema plus dexamethasone versus enema alone

Enema plus dexamethasone versus enema alone summary of findings table

Patient or population: children with intussusception
Setting: single centre, in‐patient setting
Intervention: enema plus dexamethasone
Comparison: enema alone

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

Number of participants
(studies)

Quality of the evidence
(GRADE)

Risk with enema alone

Risk with enema plus dexamethasone

Successfully reduced intussusception

Study population

RR 1.01
(0.92 to 1.10)

356
(2 studies)

Lowa

157 per 1000

159 per 1000
(144 to 173)

Moderate

771 per 1000

779 per 1000
(710 to 849)

Bowel perforation(s)

Study population

RR 2.63
(0.11 to 62.66)

75
(1 study)

Lowb,c

125 per 1000

329 per 1000
(14 to 1000)

Moderate

125 per 1000

48 per 1000
(3 to 995)

Recurrent intussusception

(follow‐up: 6 months)

Study population

RR 0.14
(0.03 to 0.60)

299
(2 studies)

Lowa

69 per 1000

10 per 1000
(2 to 42)

Moderate

370 per 1000

52 per 1000
(11 to 222)

Bowel resection

Study population

RR 0.88
(0.19 to 4.06)

75
(1 study)

Lowb,c

86 per 1000

75 per 1000
(16 to 348)

Moderate

375 per 1000

330 per 1000
(71 to 1000)

Postoperative complication(s)

Outcome not reported in any studies

*The risk in the intervention group (and its 95% confidence interval) is based on assumed risk in the comparison group and relative effect of the intervention (and its 95% CI)
CI: confidence interval; RR: risk ratio

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to the estimate of effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aDowngraded two levels for serious concerns for high risk of attrition and performance bias

bDowngraded one level for serious imprecision (95% CI is wide and includes null effect)

cDowngraded one level for concerns for high risk of performance bias

Figuras y tablas -
Summary of findings 2. Enema plus dexamethasone versus enema alone
Summary of findings 3. Air enema versus liquid enema

Air enema versus liquid enema summary of findings table

Patient or population: children with intussusception
Setting: single centre, in‐hospital setting
Intervention: air enema
Comparison: liquid contrast enema

Outcomes

Anticipated absolute effects* (95% CI)

Relative effect
(95% CI)

Number of participants
(studies)

Quality of the evidence
(GRADE)

Risk with liquid contrast enema

Risk with air enema

Successfully reduced intussusception

Study population

RR 1.28
(1.10 to 1.49)

199
(2 studies)

Lowa

677 per 1000

867 per 1000
(745 to 1000)

Moderate

712 per 1000

911 per 1000
(783 to 1000)

Bowel perforation(s)

Outcome not reported in any studies

Recurrence of intussusception

(follow‐up: 6 months)

Outcome not reported in any studies

Bowel resection

Outcome not reported in any studies

Postoperative complication(s)

Outcome not reported in any studies

*The risk in the intervention group (and its 95% confidence interval) is based on assumed risk in the comparison group and relative effect of the intervention (and its 95% CI)
CI: confidence interval; RR: risk ratio

GRADE Working Group grades of evidence
High quality: We are very confident that the true effect lies close to the estimate of effect
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of effect but may be substantially different
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of effect
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect

aDowngraded two levels for serious concerns for high risk of selection, performance, and detection bias

Figuras y tablas -
Summary of findings 3. Air enema versus liquid enema
Comparison 1. Enema plus glucagon versus enema alone

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Successfully reduced intussusception Show forest plot

2

218

Risk Ratio (M‐H, Fixed, 95% CI)

1.09 [0.94, 1.26]

Figuras y tablas -
Comparison 1. Enema plus glucagon versus enema alone
Comparison 2. Enema plus dexamethasone versus enema alone

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Successfully reduced intussusception Show forest plot

2

356

Risk Ratio (M‐H, Fixed, 95% CI)

1.01 [0.92, 1.10]

2 Bowel perforation(s) Show forest plot

1

75

Risk Ratio (M‐H, Fixed, 95% CI)

2.63 [0.11, 62.66]

3 Recurrent intussusception Show forest plot

2

299

Risk Ratio (M‐H, Fixed, 95% CI)

0.14 [0.03, 0.60]

4 Bowel resection Show forest plot

1

75

Risk Ratio (M‐H, Fixed, 95% CI)

0.88 [0.19, 4.06]

Figuras y tablas -
Comparison 2. Enema plus dexamethasone versus enema alone
Comparison 3. Air enema versus liquid enema

Outcome or subgroup title

No. of studies

No. of participants

Statistical method

Effect size

1 Successfully reduced intussusception Show forest plot

2

199

Risk Ratio (M‐H, Fixed, 95% CI)

1.28 [1.10, 1.49]

Figuras y tablas -
Comparison 3. Air enema versus liquid enema